

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 7.54522355 |
| 2 | mitochondrion transport along microtubule (GO:0047497) | 7.54522355 |
| 3 | establishment of mitochondrion localization (GO:0051654) | 6.54149726 |
| 4 | membrane budding (GO:0006900) | 6.34353693 |
| 5 | protein neddylation (GO:0045116) | 5.63949156 |
| 6 | zinc ion transmembrane transport (GO:0071577) | 5.38333704 |
| 7 | long term synaptic depression (GO:0060292) | 5.32228607 |
| 8 | apoptotic DNA fragmentation (GO:0006309) | 5.28072648 |
| 9 | thrombin receptor signaling pathway (GO:0070493) | 5.07520703 |
| 10 | regulation of female receptivity (GO:0045924) | 4.91775028 |
| 11 | positive regulation of lamellipodium assembly (GO:0010592) | 4.80573823 |
| 12 | positive regulation of Rho protein signal transduction (GO:0035025) | 4.70980544 |
| 13 | regulation of germinal center formation (GO:0002634) | 4.61411811 |
| 14 | tRNA methylation (GO:0030488) | 4.55054564 |
| 15 | regulation of transmission of nerve impulse (GO:0051969) | 4.51650072 |
| 16 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 4.25727005 |
| 17 | regulation of lipoprotein metabolic process (GO:0050746) | 4.23250774 |
| 18 | execution phase of apoptosis (GO:0097194) | 4.19980385 |
| 19 | female mating behavior (GO:0060180) | 4.18979318 |
| 20 | regulation of cholesterol efflux (GO:0010874) | 4.18091805 |
| 21 | peptidyl-histidine modification (GO:0018202) | 4.14755513 |
| 22 | negative regulation of protein oligomerization (GO:0032460) | 4.00850371 |
| 23 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 4.00689887 |
| 24 | positive regulation of isotype switching (GO:0045830) | 3.85760221 |
| 25 | positive regulation of systemic arterial blood pressure (GO:0003084) | 3.77853910 |
| 26 | sequestering of actin monomers (GO:0042989) | 3.77142773 |
| 27 | actin nucleation (GO:0045010) | 3.76876313 |
| 28 | fusion of sperm to egg plasma membrane (GO:0007342) | 3.75192490 |
| 29 | zinc ion homeostasis (GO:0055069) | 3.75019437 |
| 30 | auditory receptor cell stereocilium organization (GO:0060088) | 3.67697714 |
| 31 | phenol-containing compound catabolic process (GO:0019336) | 3.60239698 |
| 32 | lipoxygenase pathway (GO:0019372) | 3.59411529 |
| 33 | male meiosis (GO:0007140) | 3.58794793 |
| 34 | positive regulation of lamellipodium organization (GO:1902745) | 3.56135023 |
| 35 | energy homeostasis (GO:0097009) | 3.53117354 |
| 36 | TOR signaling (GO:0031929) | 3.48183035 |
| 37 | regulation of platelet aggregation (GO:0090330) | 3.43418698 |
| 38 | positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:00357 | 3.41640083 |
| 39 | mannose metabolic process (GO:0006013) | 3.40878929 |
| 40 | prenylation (GO:0097354) | 3.39806338 |
| 41 | protein prenylation (GO:0018342) | 3.39806338 |
| 42 | positive regulation of DNA recombination (GO:0045911) | 3.39585678 |
| 43 | positive regulation of endothelial cell differentiation (GO:0045603) | 3.39227517 |
| 44 | valine metabolic process (GO:0006573) | 3.38763671 |
| 45 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.37094744 |
| 46 | G-protein coupled receptor internalization (GO:0002031) | 3.32179136 |
| 47 | cardiolipin metabolic process (GO:0032048) | 3.31969994 |
| 48 | blood coagulation, intrinsic pathway (GO:0007597) | 3.30599248 |
| 49 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 3.28265446 |
| 50 | beta-amyloid metabolic process (GO:0050435) | 3.26298784 |
| 51 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 3.23374071 |
| 52 | regulation of platelet activation (GO:0010543) | 3.22790822 |
| 53 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 3.19951787 |
| 54 | multicellular organism reproduction (GO:0032504) | 3.18053011 |
| 55 | mitochondrion localization (GO:0051646) | 3.15550879 |
| 56 | aggressive behavior (GO:0002118) | 3.13062128 |
| 57 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.12157607 |
| 58 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.10028431 |
| 59 | high-density lipoprotein particle remodeling (GO:0034375) | 3.09569593 |
| 60 | zinc ion transport (GO:0006829) | 3.08878189 |
| 61 | negative regulation of cAMP-mediated signaling (GO:0043951) | 3.07452178 |
| 62 | negative regulation of norepinephrine secretion (GO:0010700) | 3.03940814 |
| 63 | positive regulation of amino acid transport (GO:0051957) | 3.03391224 |
| 64 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.97832840 |
| 65 | neutrophil activation involved in immune response (GO:0002283) | 2.97375186 |
| 66 | platelet aggregation (GO:0070527) | 2.95731103 |
| 67 | positive regulation of B cell mediated immunity (GO:0002714) | 2.91583158 |
| 68 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.91583158 |
| 69 | reverse cholesterol transport (GO:0043691) | 2.90894219 |
| 70 | adenosine receptor signaling pathway (GO:0001973) | 2.89712185 |
| 71 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.89583678 |
| 72 | positive regulation of transcription from RNA polymerase III promoter (GO:0045945) | 2.87362727 |
| 73 | pentose metabolic process (GO:0019321) | 2.85923676 |
| 74 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.85087012 |
| 75 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.85087012 |
| 76 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.83228231 |
| 77 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 2.83190852 |
| 78 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.81858140 |
| 79 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.81858140 |
| 80 | regulation of integrin activation (GO:0033623) | 2.80253967 |
| 81 | negative regulation of lipid storage (GO:0010888) | 2.79287983 |
| 82 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.78162660 |
| 83 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 2.77092518 |
| 84 | ADP metabolic process (GO:0046031) | 2.76665154 |
| 85 | RNA destabilization (GO:0050779) | 2.74999366 |
| 86 | positive regulation of prostaglandin secretion (GO:0032308) | 2.72110208 |
| 87 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 2.71222596 |
| 88 | relaxation of smooth muscle (GO:0044557) | 2.70190376 |
| 89 | low-density lipoprotein particle remodeling (GO:0034374) | 2.69996530 |
| 90 | plasma membrane fusion (GO:0045026) | 2.69335984 |
| 91 | positive regulation of organic acid transport (GO:0032892) | 2.69332888 |
| 92 | regulation of catecholamine metabolic process (GO:0042069) | 2.67313871 |
| 93 | regulation of dopamine metabolic process (GO:0042053) | 2.67313871 |
| 94 | regulation of glutamate secretion (GO:0014048) | 2.66262199 |
| 95 | phosphatidic acid biosynthetic process (GO:0006654) | 2.66089338 |
| 96 | phosphatidic acid metabolic process (GO:0046473) | 2.66089338 |
| 97 | positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511) | 2.65256363 |
| 98 | dicarboxylic acid catabolic process (GO:0043649) | 2.63839879 |
| 99 | oxidative demethylation (GO:0070989) | 2.63351170 |
| 100 | neurotransmitter catabolic process (GO:0042135) | 2.63337985 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 5.17036997 |
| 2 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 4.98574007 |
| 3 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 3.32030609 |
| 4 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 2.90716221 |
| 5 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.69488300 |
| 6 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.45290172 |
| 7 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.38355238 |
| 8 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 2.32632647 |
| 9 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.28453464 |
| 10 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.24475257 |
| 11 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.19786331 |
| 12 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 2.17473279 |
| 13 | STAT1_20625510_ChIP-Seq_HELA_Human | 2.14705739 |
| 14 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 2.13367995 |
| 15 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.12799165 |
| 16 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.00472246 |
| 17 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 11.1882357 |
| 18 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.91659779 |
| 19 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.83437911 |
| 20 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.79619009 |
| 21 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.78175071 |
| 22 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.77195353 |
| 23 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.66571710 |
| 24 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.61791050 |
| 25 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.60524176 |
| 26 | SPI1_23127762_ChIP-Seq_K562_Human | 1.59916575 |
| 27 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.55693101 |
| 28 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.54332839 |
| 29 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.54157705 |
| 30 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.53966003 |
| 31 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.47012518 |
| 32 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.45820328 |
| 33 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.43956274 |
| 34 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.33725934 |
| 35 | GATA1_19941826_ChIP-Seq_K562_Human | 1.30707638 |
| 36 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.28036844 |
| 37 | WDR5_24793694_ChIP-Seq_LNCAP_Human | 1.24482433 |
| 38 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.20332574 |
| 39 | P300_27268052_Chip-Seq_Bcells_Human | 1.19168796 |
| 40 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.18639190 |
| 41 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.18606442 |
| 42 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.17678247 |
| 43 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.15427581 |
| 44 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.14615486 |
| 45 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.14157752 |
| 46 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.13205130 |
| 47 | SOX2_21211035_ChIP-Seq_LN229_Human | 1.09707147 |
| 48 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.09627116 |
| 49 | GATA1_22025678_ChIP-Seq_K562_Human | 1.08683265 |
| 50 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.04886233 |
| 51 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.04886233 |
| 52 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.04740111 |
| 53 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.03985588 |
| 54 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.03089812 |
| 55 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.03040410 |
| 56 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 1.02446605 |
| 57 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.01038682 |
| 58 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.00905824 |
| 59 | P68_20966046_ChIP-Seq_HELA_Human | 1.00897304 |
| 60 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.00337274 |
| 61 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.00225904 |
| 62 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.99784948 |
| 63 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.97478907 |
| 64 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.96863101 |
| 65 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.96512119 |
| 66 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.93948105 |
| 67 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.93811169 |
| 68 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.92145939 |
| 69 | BCL6_25482012_ChIP-Seq_CML-JURL-MK1_Human | 0.91391870 |
| 70 | GATA2_19941826_ChIP-Seq_K562_Human | 0.90311335 |
| 71 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.87552477 |
| 72 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.85094115 |
| 73 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.84840834 |
| 74 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.84491954 |
| 75 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.84356287 |
| 76 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.84256424 |
| 77 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.81422116 |
| 78 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 0.80090882 |
| 79 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.80020672 |
| 80 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.79373171 |
| 81 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.78865245 |
| 82 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.78510879 |
| 83 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.76805538 |
| 84 | SOX2_22085726_ChIP-Seq_NPCs_Mouse | 0.76631315 |
| 85 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.76242985 |
| 86 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.75855702 |
| 87 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.74175539 |
| 88 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.73711513 |
| 89 | SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 0.73629246 |
| 90 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.72602597 |
| 91 | MYB_26560356_Chip-Seq_TH2_Human | 0.72345130 |
| 92 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.71406057 |
| 93 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.70282091 |
| 94 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.70134896 |
| 95 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.68586088 |
| 96 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 0.67807635 |
| 97 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.66825908 |
| 98 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.65382127 |
| 99 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.63503887 |
| 100 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.62990865 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003724_increased_susceptibility_to | 4.95212136 |
| 2 | MP0003806_abnormal_nucleotide_metabolis | 4.84006602 |
| 3 | MP0005464_abnormal_platelet_physiology | 4.67426280 |
| 4 | MP0009278_abnormal_bone_marrow | 4.60986534 |
| 5 | MP0003303_peritoneal_inflammation | 4.29806527 |
| 6 | MP0000569_abnormal_digit_pigmentation | 4.13564944 |
| 7 | MP0001545_abnormal_hematopoietic_system | 3.37725529 |
| 8 | MP0005397_hematopoietic_system_phenotyp | 3.37725529 |
| 9 | MP0004130_abnormal_muscle_cell | 3.18468360 |
| 10 | MP0008875_abnormal_xenobiotic_pharmacok | 3.01473406 |
| 11 | MP0005410_abnormal_fertilization | 2.72579123 |
| 12 | MP0003718_maternal_effect | 2.67523939 |
| 13 | MP0008004_abnormal_stomach_pH | 2.50339644 |
| 14 | MP0002653_abnormal_ependyma_morphology | 2.29218029 |
| 15 | MP0000465_gastrointestinal_hemorrhage | 1.98555296 |
| 16 | MP0003656_abnormal_erythrocyte_physiolo | 1.97407895 |
| 17 | MP0002332_abnormal_exercise_endurance | 1.96373726 |
| 18 | MP0004233_abnormal_muscle_weight | 1.95034880 |
| 19 | MP0003828_pulmonary_edema | 1.74410065 |
| 20 | MP0005645_abnormal_hypothalamus_physiol | 1.58180227 |
| 21 | MP0005083_abnormal_biliary_tract | 1.52518128 |
| 22 | MP0006036_abnormal_mitochondrial_physio | 1.51780943 |
| 23 | MP0002269_muscular_atrophy | 1.48684811 |
| 24 | MP0003436_decreased_susceptibility_to | 1.45857610 |
| 25 | MP0005058_abnormal_lysosome_morphology | 1.45394425 |
| 26 | MP0004742_abnormal_vestibular_system | 1.43595631 |
| 27 | MP0001533_abnormal_skeleton_physiology | 1.36511523 |
| 28 | MP0000230_abnormal_systemic_arterial | 1.36070932 |
| 29 | MP0009333_abnormal_splenocyte_physiolog | 1.35972476 |
| 30 | MP0005076_abnormal_cell_differentiation | 1.33981138 |
| 31 | MP0005084_abnormal_gallbladder_morpholo | 1.33663127 |
| 32 | MP0003191_abnormal_cellular_cholesterol | 1.33036919 |
| 33 | MP0001764_abnormal_homeostasis | 1.32684386 |
| 34 | MP0005266_abnormal_metabolism | 1.28230126 |
| 35 | MP0001501_abnormal_sleep_pattern | 1.25634716 |
| 36 | MP0005167_abnormal_blood-brain_barrier | 1.22908816 |
| 37 | MP0004036_abnormal_muscle_relaxation | 1.16834057 |
| 38 | MP0005174_abnormal_tail_pigmentation | 1.15557374 |
| 39 | MP0001835_abnormal_antigen_presentation | 1.13682134 |
| 40 | MP0001905_abnormal_dopamine_level | 1.13397537 |
| 41 | MP0005647_abnormal_sex_gland | 1.12247949 |
| 42 | MP0005376_homeostasis/metabolism_phenot | 1.08887492 |
| 43 | MP0002723_abnormal_immune_serum | 1.08809413 |
| 44 | MP0001664_abnormal_digestion | 1.05581020 |
| 45 | MP0000343_altered_response_to | 1.05247889 |
| 46 | MP0005408_hypopigmentation | 1.04876093 |
| 47 | MP0003959_abnormal_lean_body | 1.04009194 |
| 48 | MP0004084_abnormal_cardiac_muscle | 1.03752984 |
| 49 | MP0002971_abnormal_brown_adipose | 1.02488312 |
| 50 | MP0005000_abnormal_immune_tolerance | 1.01712526 |
| 51 | MP0003195_calcinosis | 1.00095064 |
| 52 | MP0009840_abnormal_foam_cell | 0.99452166 |
| 53 | MP0004510_myositis | 0.95561129 |
| 54 | MP0010329_abnormal_lipoprotein_level | 0.95175786 |
| 55 | MP0005448_abnormal_energy_balance | 0.94878475 |
| 56 | MP0009115_abnormal_fat_cell | 0.91484363 |
| 57 | MP0003638_abnormal_response/metabolism_ | 0.91238394 |
| 58 | MP0004085_abnormal_heartbeat | 0.90298279 |
| 59 | MP0005025_abnormal_response_to | 0.89911951 |
| 60 | MP0002398_abnormal_bone_marrow | 0.89884439 |
| 61 | MP0002419_abnormal_innate_immunity | 0.89839985 |
| 62 | MP0001800_abnormal_humoral_immune | 0.87880197 |
| 63 | MP0002452_abnormal_antigen_presenting | 0.87122396 |
| 64 | MP0002429_abnormal_blood_cell | 0.87009871 |
| 65 | MP0001944_abnormal_pancreas_morphology | 0.85490338 |
| 66 | MP0010155_abnormal_intestine_physiology | 0.85365397 |
| 67 | MP0002132_abnormal_respiratory_system | 0.84217936 |
| 68 | MP0000716_abnormal_immune_system | 0.83858743 |
| 69 | MP0005595_abnormal_vascular_smooth | 0.81586638 |
| 70 | MP0000689_abnormal_spleen_morphology | 0.80345042 |
| 71 | MP0005334_abnormal_fat_pad | 0.78625778 |
| 72 | MP0005636_abnormal_mineral_homeostasis | 0.77880353 |
| 73 | MP0004947_skin_inflammation | 0.74547322 |
| 74 | MP0003186_abnormal_redox_activity | 0.74484556 |
| 75 | MP0000015_abnormal_ear_pigmentation | 0.74297627 |
| 76 | MP0002972_abnormal_cardiac_muscle | 0.73894535 |
| 77 | MP0001819_abnormal_immune_cell | 0.73288398 |
| 78 | MP0002420_abnormal_adaptive_immunity | 0.73170593 |
| 79 | MP0001845_abnormal_inflammatory_respons | 0.73165916 |
| 80 | MP0001663_abnormal_digestive_system | 0.71063972 |
| 81 | MP0006276_abnormal_autonomic_nervous | 0.69562319 |
| 82 | MP0001765_abnormal_ion_homeostasis | 0.69367317 |
| 83 | MP0005646_abnormal_pituitary_gland | 0.69268443 |
| 84 | MP0000703_abnormal_thymus_morphology | 0.69163618 |
| 85 | MP0003075_altered_response_to | 0.68178658 |
| 86 | MP0005390_skeleton_phenotype | 0.67994829 |
| 87 | MP0008260_abnormal_autophagy | 0.67113139 |
| 88 | MP0003698_abnormal_male_reproductive | 0.66329360 |
| 89 | MP0002736_abnormal_nociception_after | 0.65399699 |
| 90 | MP0001191_abnormal_skin_condition | 0.65018917 |
| 91 | MP0009642_abnormal_blood_homeostasis | 0.64900347 |
| 92 | MP0003879_abnormal_hair_cell | 0.64285248 |
| 93 | MP0009046_muscle_twitch | 0.63704373 |
| 94 | MP0006138_congestive_heart_failure | 0.63187375 |
| 95 | MP0002118_abnormal_lipid_homeostasis | 0.62739365 |
| 96 | MP0008775_abnormal_heart_ventricle | 0.62721938 |
| 97 | MP0000249_abnormal_blood_vessel | 0.62668214 |
| 98 | MP0001853_heart_inflammation | 0.62662971 |
| 99 | MP0002148_abnormal_hypersensitivity_rea | 0.62266463 |
| 100 | MP0005620_abnormal_muscle_contractility | 0.60967434 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Microvesicular hepatic steatosis (HP:0001414) | 9.28155285 |
| 2 | Prolonged bleeding time (HP:0003010) | 5.73376399 |
| 3 | Abnormal number of erythroid precursors (HP:0012131) | 5.49701783 |
| 4 | Hyperthyroidism (HP:0000836) | 5.34088850 |
| 5 | Menorrhagia (HP:0000132) | 5.26964493 |
| 6 | Increased mean platelet volume (HP:0011877) | 5.23523198 |
| 7 | Petechiae (HP:0000967) | 5.01312610 |
| 8 | Seborrheic dermatitis (HP:0001051) | 4.99499956 |
| 9 | Decreased central vision (HP:0007663) | 4.95766367 |
| 10 | Abnormal platelet volume (HP:0011876) | 4.85133727 |
| 11 | Purpura (HP:0000979) | 4.65874182 |
| 12 | Abnormality of cells of the erythroid lineage (HP:0012130) | 4.57267652 |
| 13 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 4.56105156 |
| 14 | Hypochromic anemia (HP:0001931) | 4.43474934 |
| 15 | Epistaxis (HP:0000421) | 4.06311697 |
| 16 | Hypertensive crisis (HP:0100735) | 3.62959661 |
| 17 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.62866292 |
| 18 | Dicarboxylic aciduria (HP:0003215) | 3.62866292 |
| 19 | Progressive muscle weakness (HP:0003323) | 3.52581149 |
| 20 | Abnormal pupillary function (HP:0007686) | 3.45748334 |
| 21 | Obstructive lung disease (HP:0006536) | 3.39586607 |
| 22 | Chronic obstructive pulmonary disease (HP:0006510) | 3.39586607 |
| 23 | Abnormality of transition element cation homeostasis (HP:0011030) | 3.23304392 |
| 24 | Type 2 muscle fiber atrophy (HP:0003554) | 3.23064764 |
| 25 | Increased serum ferritin (HP:0003281) | 3.22481689 |
| 26 | Abnormality of iron homeostasis (HP:0011031) | 3.19531113 |
| 27 | Abnormal rod and cone electroretinograms (HP:0008323) | 3.11055399 |
| 28 | Foot dorsiflexor weakness (HP:0009027) | 3.10066947 |
| 29 | Cerebral edema (HP:0002181) | 3.09839946 |
| 30 | Stroke (HP:0001297) | 3.06555811 |
| 31 | Gingival bleeding (HP:0000225) | 2.97467722 |
| 32 | Severe visual impairment (HP:0001141) | 2.92954783 |
| 33 | Muscle fiber atrophy (HP:0100295) | 2.89006770 |
| 34 | Clumsiness (HP:0002312) | 2.86678659 |
| 35 | Attenuation of retinal blood vessels (HP:0007843) | 2.85122860 |
| 36 | Increased density of long bones (HP:0006392) | 2.78336094 |
| 37 | Abnormality of the foot musculature (HP:0001436) | 2.75552682 |
| 38 | Abnormal platelet function (HP:0011869) | 2.74840717 |
| 39 | Impaired platelet aggregation (HP:0003540) | 2.74840717 |
| 40 | Hyperlipoproteinemia (HP:0010980) | 2.74127214 |
| 41 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.74027347 |
| 42 | Truncus arteriosus (HP:0001660) | 2.72415950 |
| 43 | Upper limb muscle weakness (HP:0003484) | 2.70563948 |
| 44 | Pustule (HP:0200039) | 2.70002378 |
| 45 | Ketoacidosis (HP:0001993) | 2.52617176 |
| 46 | Flat capital femoral epiphysis (HP:0003370) | 2.50241938 |
| 47 | Spontaneous hematomas (HP:0007420) | 2.45361482 |
| 48 | Anomalous pulmonary venous return (HP:0010772) | 2.45318400 |
| 49 | Poikilocytosis (HP:0004447) | 2.43763984 |
| 50 | Eosinophilia (HP:0001880) | 2.42473704 |
| 51 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.36612648 |
| 52 | Pigmentary retinal degeneration (HP:0001146) | 2.35125238 |
| 53 | Granulocytopenia (HP:0001913) | 2.33570629 |
| 54 | Abnormality of the prostate (HP:0008775) | 2.25820897 |
| 55 | Hammertoe (HP:0001765) | 2.25626612 |
| 56 | Hypoparathyroidism (HP:0000829) | 2.24116111 |
| 57 | Ketosis (HP:0001946) | 2.23092649 |
| 58 | Atelectasis (HP:0100750) | 2.20541218 |
| 59 | Nonprogressive disorder (HP:0003680) | 2.18566214 |
| 60 | Biliary tract neoplasm (HP:0100574) | 2.16982867 |
| 61 | Fatigable weakness (HP:0003473) | 2.15535524 |
| 62 | Abnormality of the neuromuscular junction (HP:0003398) | 2.15535524 |
| 63 | Increased IgM level (HP:0003496) | 2.14275254 |
| 64 | Abnormality of the tricuspid valve (HP:0001702) | 2.10522485 |
| 65 | Acanthocytosis (HP:0001927) | 2.10048448 |
| 66 | Abnormality of the pulmonary veins (HP:0011718) | 2.09160341 |
| 67 | Genetic anticipation (HP:0003743) | 2.09035969 |
| 68 | Microcytic anemia (HP:0001935) | 2.08079491 |
| 69 | Stomach cancer (HP:0012126) | 2.07811071 |
| 70 | Impaired vibratory sensation (HP:0002495) | 2.07402113 |
| 71 | Delayed puberty (HP:0000823) | 2.06740799 |
| 72 | Weak cry (HP:0001612) | 2.05823909 |
| 73 | Easy fatigability (HP:0003388) | 2.04607961 |
| 74 | Metabolic alkalosis (HP:0200114) | 2.03103006 |
| 75 | Decreased muscle mass (HP:0003199) | 2.00956187 |
| 76 | Abnormal ciliary motility (HP:0012262) | 2.00136805 |
| 77 | Exercise intolerance (HP:0003546) | 1.97182446 |
| 78 | Bruising susceptibility (HP:0000978) | 1.96472615 |
| 79 | Progressive cerebellar ataxia (HP:0002073) | 1.96252993 |
| 80 | Hypokalemic alkalosis (HP:0001949) | 1.96162177 |
| 81 | Fasciculations (HP:0002380) | 1.95318675 |
| 82 | Abnormal large intestine physiology (HP:0012700) | 1.92759770 |
| 83 | Hypocalcemia (HP:0002901) | 1.91592615 |
| 84 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.90137240 |
| 85 | Macular degeneration (HP:0000608) | 1.87964955 |
| 86 | Autoimmune thrombocytopenia (HP:0001973) | 1.83714466 |
| 87 | Fair hair (HP:0002286) | 1.82641732 |
| 88 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.80679881 |
| 89 | Generalized amyotrophy (HP:0003700) | 1.80329163 |
| 90 | Slender long bone (HP:0003100) | 1.79987233 |
| 91 | Bowel incontinence (HP:0002607) | 1.78800573 |
| 92 | Venous insufficiency (HP:0005293) | 1.78441313 |
| 93 | Dyschromatopsia (HP:0007641) | 1.76303910 |
| 94 | Absent/shortened dynein arms (HP:0200106) | 1.75556553 |
| 95 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.75556553 |
| 96 | Rimmed vacuoles (HP:0003805) | 1.73878140 |
| 97 | Pulmonary fibrosis (HP:0002206) | 1.73697136 |
| 98 | Right ventricular cardiomyopathy (HP:0011663) | 1.72456786 |
| 99 | Abnormality of lateral ventricle (HP:0030047) | 1.72430864 |
| 100 | Abnormality of eosinophils (HP:0001879) | 1.70790208 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ICK | 8.09992079 |
| 2 | PTK2B | 4.96402221 |
| 3 | IKBKB | 3.15120418 |
| 4 | STK38 | 2.86412854 |
| 5 | MAP2K2 | 2.83589454 |
| 6 | LMTK2 | 2.61829484 |
| 7 | JAK3 | 2.35120949 |
| 8 | BMX | 2.31928144 |
| 9 | TXK | 2.27202829 |
| 10 | BTK | 2.18192412 |
| 11 | NME2 | 2.16143690 |
| 12 | RET | 2.11190394 |
| 13 | MAPK11 | 2.00224216 |
| 14 | TNK2 | 1.95547672 |
| 15 | PRKD2 | 1.89277242 |
| 16 | PINK1 | 1.89117465 |
| 17 | MARK3 | 1.87126403 |
| 18 | MYLK | 1.85393411 |
| 19 | BMPR2 | 1.73136413 |
| 20 | RPS6KC1 | 1.71654837 |
| 21 | RPS6KL1 | 1.71654837 |
| 22 | RIPK4 | 1.69358203 |
| 23 | RPS6KA6 | 1.67252575 |
| 24 | TEC | 1.64436228 |
| 25 | SYK | 1.48841265 |
| 26 | OBSCN | 1.46082512 |
| 27 | PIK3CG | 1.10805988 |
| 28 | MST4 | 1.09198972 |
| 29 | STK16 | 1.07439723 |
| 30 | TBK1 | 1.06098502 |
| 31 | BRSK2 | 1.05952493 |
| 32 | FLT3 | 1.03297980 |
| 33 | IKBKE | 1.01616594 |
| 34 | CAMKK2 | 0.98737281 |
| 35 | KDR | 0.97519385 |
| 36 | FRK | 0.97229766 |
| 37 | RPS6KA5 | 0.94690133 |
| 38 | DAPK2 | 0.87948658 |
| 39 | PHKG2 | 0.85292132 |
| 40 | PHKG1 | 0.85292132 |
| 41 | MATK | 0.85172214 |
| 42 | TESK2 | 0.85168318 |
| 43 | PAK1 | 0.81567314 |
| 44 | RPS6KA1 | 0.76916570 |
| 45 | PBK | 0.72770446 |
| 46 | MAP2K1 | 0.71882644 |
| 47 | LCK | 0.71295872 |
| 48 | RPS6KA2 | 0.70596531 |
| 49 | DYRK1A | 0.65078017 |
| 50 | CSF1R | 0.64674126 |
| 51 | ZAP70 | 0.63931857 |
| 52 | FYN | 0.63930401 |
| 53 | STK3 | 0.62611393 |
| 54 | GRK5 | 0.61127366 |
| 55 | JAK2 | 0.59673148 |
| 56 | LYN | 0.59555160 |
| 57 | MAPKAPK5 | 0.59005417 |
| 58 | MAP3K7 | 0.55547742 |
| 59 | ADRBK2 | 0.55207295 |
| 60 | FGR | 0.54430311 |
| 61 | PDK2 | 0.53030093 |
| 62 | AKT3 | 0.52748654 |
| 63 | PDK1 | 0.52685333 |
| 64 | CDK9 | 0.48796102 |
| 65 | MAPK4 | 0.48682286 |
| 66 | STK38L | 0.48023583 |
| 67 | ILK | 0.46480390 |
| 68 | BLK | 0.46447642 |
| 69 | MAPK3 | 0.46310318 |
| 70 | DAPK3 | 0.45800124 |
| 71 | ABL1 | 0.44557285 |
| 72 | MAPKAPK3 | 0.41152650 |
| 73 | TLK1 | 0.38631093 |
| 74 | PRKAA1 | 0.38402602 |
| 75 | PRKCQ | 0.37145031 |
| 76 | STK39 | 0.36454643 |
| 77 | MAPKAPK2 | 0.36071607 |
| 78 | MAPK12 | 0.35791913 |
| 79 | MAPK7 | 0.35499278 |
| 80 | MAP3K14 | 0.34464302 |
| 81 | MAPK1 | 0.34174442 |
| 82 | SRC | 0.33004506 |
| 83 | WNK4 | 0.31894771 |
| 84 | PDPK1 | 0.31037363 |
| 85 | INSR | 0.31037359 |
| 86 | GRK1 | 0.30902080 |
| 87 | AKT1 | 0.30361920 |
| 88 | CAMK1 | 0.30073277 |
| 89 | RPS6KA3 | 0.29381314 |
| 90 | GRK6 | 0.29181220 |
| 91 | DYRK3 | 0.28386584 |
| 92 | PRKD1 | 0.28260580 |
| 93 | SGK1 | 0.26742885 |
| 94 | PRKACG | 0.25866774 |
| 95 | MET | 0.25863128 |
| 96 | CSK | 0.25772978 |
| 97 | STK11 | 0.24818544 |
| 98 | ITK | 0.23612904 |
| 99 | NTRK1 | 0.22026675 |
| 100 | DYRK1B | 0.21848646 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Other glycan degradation_Homo sapiens_hsa00511 | 4.28588258 |
| 2 | Platelet activation_Homo sapiens_hsa04611 | 3.11398103 |
| 3 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.83165375 |
| 4 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 2.72524504 |
| 5 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.40768993 |
| 6 | Asthma_Homo sapiens_hsa05310 | 2.38861664 |
| 7 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.36676273 |
| 8 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 2.33142242 |
| 9 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.31136474 |
| 10 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.24614200 |
| 11 | Olfactory transduction_Homo sapiens_hsa04740 | 2.15870131 |
| 12 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.07723421 |
| 13 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 2.00700733 |
| 14 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 2.00547055 |
| 15 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.87099648 |
| 16 | Allograft rejection_Homo sapiens_hsa05330 | 1.82097555 |
| 17 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.74906898 |
| 18 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.69033381 |
| 19 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.66742512 |
| 20 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.57465266 |
| 21 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.53400655 |
| 22 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.52679788 |
| 23 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.39525243 |
| 24 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.38716823 |
| 25 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.37840676 |
| 26 | Viral myocarditis_Homo sapiens_hsa05416 | 1.29407265 |
| 27 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.28317170 |
| 28 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.27816014 |
| 29 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.27623395 |
| 30 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.23147341 |
| 31 | Phototransduction_Homo sapiens_hsa04744 | 1.19780733 |
| 32 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.11252927 |
| 33 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.08925773 |
| 34 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.07123606 |
| 35 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.04532517 |
| 36 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.03053323 |
| 37 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.02867795 |
| 38 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.01031805 |
| 39 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.00128925 |
| 40 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.99454687 |
| 41 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.92842368 |
| 42 | Alcoholism_Homo sapiens_hsa05034 | 0.92514693 |
| 43 | Legionellosis_Homo sapiens_hsa05134 | 0.84455839 |
| 44 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.83816842 |
| 45 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.77890957 |
| 46 | ABC transporters_Homo sapiens_hsa02010 | 0.74859549 |
| 47 | Peroxisome_Homo sapiens_hsa04146 | 0.74614373 |
| 48 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.74349098 |
| 49 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.73432634 |
| 50 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.73390248 |
| 51 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.70124044 |
| 52 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.69730391 |
| 53 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.67978529 |
| 54 | Leishmaniasis_Homo sapiens_hsa05140 | 0.67305517 |
| 55 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.67159812 |
| 56 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.65937307 |
| 57 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.65183954 |
| 58 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.64044847 |
| 59 | Measles_Homo sapiens_hsa05162 | 0.63720747 |
| 60 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.63451536 |
| 61 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.63309466 |
| 62 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.61949989 |
| 63 | Retinol metabolism_Homo sapiens_hsa00830 | 0.61277477 |
| 64 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.60912565 |
| 65 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.59076721 |
| 66 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.58630579 |
| 67 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.58382055 |
| 68 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.58283743 |
| 69 | Gap junction_Homo sapiens_hsa04540 | 0.57254724 |
| 70 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.56665503 |
| 71 | Purine metabolism_Homo sapiens_hsa00230 | 0.56443913 |
| 72 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.56316149 |
| 73 | Morphine addiction_Homo sapiens_hsa05032 | 0.56062353 |
| 74 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.55952817 |
| 75 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.53833048 |
| 76 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.52582512 |
| 77 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.51530843 |
| 78 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.50063523 |
| 79 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.49749965 |
| 80 | Apoptosis_Homo sapiens_hsa04210 | 0.49499382 |
| 81 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.48406020 |
| 82 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.48200951 |
| 83 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.48069665 |
| 84 | Renin secretion_Homo sapiens_hsa04924 | 0.47183655 |
| 85 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.46418988 |
| 86 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.45996184 |
| 87 | Phagosome_Homo sapiens_hsa04145 | 0.42585941 |
| 88 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.40024382 |
| 89 | Mineral absorption_Homo sapiens_hsa04978 | 0.39676326 |
| 90 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.39412840 |
| 91 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.39411600 |
| 92 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.38358389 |
| 93 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.38224594 |
| 94 | Endocytosis_Homo sapiens_hsa04144 | 0.37665082 |
| 95 | Circadian entrainment_Homo sapiens_hsa04713 | 0.36673201 |
| 96 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.35850014 |
| 97 | Sulfur relay system_Homo sapiens_hsa04122 | 0.35133962 |
| 98 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.35130803 |
| 99 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.34945053 |
| 100 | Histidine metabolism_Homo sapiens_hsa00340 | 0.34360814 |

